DDI Drug Name |
DDI Drug ID |
Severity |
Mechanism |
Comorbidity |
REF |
Tretinoin |
DM49DUI
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Tretinoin. |
Acne vulgaris [ED80]
|
[6] |
Isotretinoin |
DM4QTBN
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Isotretinoin. |
Acne vulgaris [ED80]
|
[6] |
Sarecycline |
DMLZNIQ
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Sarecycline . |
Acne vulgaris [ED80]
|
[6] |
Trifarotene |
DMOL793
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Trifarotene. |
Acne vulgaris [ED80]
|
[6] |
Glibenclamide |
DM8JXPZ
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Glibenclamide. |
Acute diabete complication [5A2Y]
|
[6] |
Tolazamide |
DMIHRNA
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Tolazamide. |
Acute diabete complication [5A2Y]
|
[6] |
Glipizide |
DMZA5PQ
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Glipizide. |
Acute diabete complication [5A2Y]
|
[6] |
Voriconazole |
DMAOL2S
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Voriconazole. |
Aspergillosis [1F20]
|
[6] |
Ofloxacin |
DM0VQN3
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Ofloxacin. |
Bacterial infection [1A00-1C4Z]
|
[6] |
Ciprofloxacin XR |
DM2NLS9
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Ciprofloxacin XR. |
Bacterial infection [1A00-1C4Z]
|
[6] |
Trovafloxacin |
DM6AN32
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Trovafloxacin. |
Bacterial infection [1A00-1C4Z]
|
[6] |
Sulfamethoxazole |
DMB08GE
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Sulfamethoxazole. |
Bacterial infection [1A00-1C4Z]
|
[6] |
Sparfloxacin |
DMB4HCT
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Sparfloxacin. |
Bacterial infection [1A00-1C4Z]
|
[6] |
Gemifloxacin |
DMHT34O
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Gemifloxacin. |
Bacterial infection [1A00-1C4Z]
|
[6] |
Norfloxacin |
DMIZ6W2
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Norfloxacin. |
Bacterial infection [1A00-1C4Z]
|
[6] |
Oxytetracycline |
DMOVH1M
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Oxytetracycline. |
Bacterial infection [1A00-1C4Z]
|
[6] |
Omadacycline |
DMR2J95
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Omadacycline. |
Bacterial infection [1A00-1C4Z]
|
[6] |
Levofloxacin |
DMS60RB
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Levofloxacin. |
Bacterial infection [1A00-1C4Z]
|
[6] |
Minocycline |
DMVN5OH
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Minocycline. |
Bacterial infection [1A00-1C4Z]
|
[6] |
Lomefloxacin |
DMVRH9C
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Lomefloxacin. |
Bacterial infection [1A00-1C4Z]
|
[6] |
Tetracycline |
DMZA017
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Tetracycline. |
Bacterial infection [1A00-1C4Z]
|
[6] |
Lapatinib |
DM3BH1Y
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Lapatinib. |
Breast cancer [2C60-2C6Y]
|
[6] |
Demeclocycline |
DMZEPFJ
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Demeclocycline. |
Bronchitis [CA20]
|
[6] |
Panitumumab |
DMQPD1F
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Panitumumab. |
Colorectal cancer [2B91]
|
[6] |
Ethacrynic acid |
DM60QMR
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Ethacrynic acid. |
Essential hypertension [BA00]
|
[6] |
Benzthiazide |
DMQWZ0H
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Benzthiazide. |
Essential hypertension [BA00]
|
[6] |
Avapritinib |
DMK2GZX
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Avapritinib. |
Gastrointestinal stromal tumour [2B5B]
|
[6] |
Acetazolamide |
DM1AF5U
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Acetazolamide. |
Glaucoma [9C61]
|
[6] |
Chlorothiazide |
DMLHESP
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Chlorothiazide. |
Heart failure [BD10-BD1Z]
|
[6] |
Furosemide |
DMMQ8ZG
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Furosemide. |
Heart failure [BD10-BD1Z]
|
[6] |
Bumetanide |
DMRV7H0
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Bumetanide. |
Heart failure [BD10-BD1Z]
|
[6] |
Hydroflumethiazide |
DMVPUQI
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Hydroflumethiazide. |
Heart failure [BD10-BD1Z]
|
[6] |
Simeprevir |
DMLUA9D
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Simeprevir. |
Hepatitis virus infection [1E50-1E51]
|
[6] |
Tipranavir |
DM8HJX6
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Tipranavir. |
Human immunodeficiency virus disease [1C60-1C62]
|
[6] |
Indapamide |
DMGN1PW
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Indapamide. |
Hypertension [BA00-BA04]
|
[6] |
Trichlormethiazide |
DMHAQCO
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Trichlormethiazide. |
Hypertension [BA00-BA04]
|
[6] |
Hydrochlorothiazide |
DMUSZHD
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Hydrochlorothiazide. |
Hypertension [BA00-BA04]
|
[6] |
Pirfenidone |
DM6VZFQ
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Pirfenidone. |
Idiopathic interstitial pneumonitis [CB03]
|
[6] |
TP-434 |
DM5A31S
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and TP-434. |
Infectious gastroenteritis/colitis [1A40]
|
[6] |
Propiomazine |
DMKY8V1
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Propiomazine. |
Insomnia [7A00-7A0Z]
|
[6] |
Alitretinoin |
DMME8LH
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Alitretinoin. |
Kaposi sarcoma [2B57]
|
[6] |
Methotrexate |
DM2TEOL
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Methotrexate. |
Leukaemia [2A60-2B33]
|
[6] |
Porfimer Sodium |
DM7ZWNY
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Porfimer Sodium. |
Lung cancer [2C25]
|
[7] |
Erlotinib |
DMCMBHA
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Erlotinib. |
Lung cancer [2C25]
|
[6] |
Alectinib |
DMP1I6Y
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Alectinib. |
Lung cancer [2C25]
|
[6] |
BIBW 2992 |
DMTKD7Q
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and BIBW 2992. |
Lung cancer [2C25]
|
[6] |
Sulphadoxine |
DMZI2UF
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Sulphadoxine. |
Malaria [1F40-1F45]
|
[6] |
Vemurafenib |
DM62UG5
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Vemurafenib. |
Melanoma [2C30]
|
[6] |
Dabrafenib |
DMX6OE3
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Dabrafenib. |
Melanoma [2C30]
|
[6] |
Methoxsalen |
DME8FZ9
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Methoxsalen. |
Mycosis fungoides [2B01]
|
[8] |
Imatinib |
DM7RJXL
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Imatinib. |
Myeloproliferative neoplasm [2A20]
|
[6] |
Promethazine |
DM6I5GR
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Promethazine. |
Nausea/vomiting [MD90]
|
[6] |
Metolazone |
DMB39LO
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Metolazone. |
Oedema [MG29]
|
[6] |
Polythiazide |
DMCH80F
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Polythiazide. |
Oedema [MG29]
|
[6] |
Valdecoxib |
DMAY7H4
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Valdecoxib. |
Osteoarthritis [FA00-FA05]
|
[6] |
Bicalutamide |
DMZMSPF
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Bicalutamide. |
Prostate cancer [2C82]
|
[6] |
Levomepromazine |
DMIKFEL
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Levomepromazine. |
Psychotic disorder [6A20-6A25]
|
[6] |
Triflupromazine |
DMKFQJP
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Triflupromazine. |
Psychotic disorder [6A20-6A25]
|
[6] |
Gatifloxacin |
DMSL679
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Gatifloxacin. |
Respiratory infection [CA07-CA4Z]
|
[6] |
Celecoxib |
DM6LOQU
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Celecoxib. |
Rheumatoid arthritis [FA20]
|
[6] |
Sulfasalazine |
DMICA9H
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Sulfasalazine. |
Rheumatoid arthritis [FA20]
|
[6] |
Mesoridazine |
DM2ZGAN
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Mesoridazine. |
Schizophrenia [6A20]
|
[6] |
Thioridazine |
DM35M8J
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Thioridazine. |
Schizophrenia [6A20]
|
[6] |
Perphenazine |
DMA4MRX
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Perphenazine. |
Schizophrenia [6A20]
|
[6] |
Chlorpromazine |
DMBGZI3
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Chlorpromazine. |
Schizophrenia [6A20]
|
[6] |
Trifluoperazine |
DMKBYWI
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Trifluoperazine. |
Schizophrenia [6A20]
|
[6] |
Tigecycline |
DMLE7IO
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Tigecycline. |
Skin and skin-structure infection [1F28-1G0Z]
|
[6] |
Imiquimod |
DM1TMA3
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Imiquimod. |
Skin cancer [2C30-2C37]
|
[6] |
Vandetanib |
DMRICNP
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Vandetanib. |
Solid tumour/cancer [2A00-2F9Z]
|
[6] |
Tolbutamide |
DM02AWV
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Tolbutamide. |
Type 2 diabetes mellitus [5A11]
|
[6] |
Chlorpropamide |
DMPHZQE
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Chlorpropamide. |
Type 2 diabetes mellitus [5A11]
|
[6] |
Cinoxacin |
DM4EWNS
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Cinoxacin. |
Urinary tract infection [GC08]
|
[6] |
Sulfamethizole |
DMGCHDS
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Sulfamethizole. |
Urinary tract infection [GC08]
|
[6] |
Nalidixic acid |
DMRM0JV
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Nalidixic acid. |
Urinary tract infection [GC08]
|
[6] |
Enoxacin |
DMYTE6L
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Enoxacin. |
Urinary tract infection [GC08]
|
[6] |
Methdilazine |
DMAUHQX
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Methdilazine. |
Vasomotor/allergic rhinitis [CA08]
|
[6] |
Trimeprazine |
DMEMV9D
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Trimeprazine. |
Vasomotor/allergic rhinitis [CA08]
|
[6] |
Amiodarone |
DMUTEX3
|
Moderate |
Increased risk of photosensitivity reactions by the combination of Verteporfin and Amiodarone. |
Ventricular tachyarrhythmia [BC71]
|
[6] |
----------- |
|
|
|
|
|